Blue Crest Capital Management LTD Volitionrx LTD Transaction History

Blue Crest Capital Management LTD

  • $1.71 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$2.93 - $3.6 $72,581 - $89,179
-24,772 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$2.19 - $3.45 $54,250 - $85,463
24,772 New
24,772 $81,000
Q3 2018

Nov 14, 2018
SELL
$1.57 - $2.59 $17,293 - $28,528
-11,015 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$2.29 - $3.95 $25,224 - $43,509
11,015 New
11,015 $26,000

Others Institutions Holding VNRX

# of Institutions
31
Shares Held
8.17M
Call Options Held
53.6K
Put Options Held
300
View Full List

About VOLITIONRX LTD

VNRX Quotes by TradingView
  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $37.2M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email